US Stock MarketDetailed Quotes

MNPR Monopar Therapeutics

Watchlist
  • 0.7272
  • +0.0672+10.18%
Close May 3 16:00 ET
  • 0.7290
  • +0.0018+0.25%
Post 19:11 ET
12.69MMarket Cap-1192P/E (TTM)

About Monopar Therapeutics Company

Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.

Company Profile

SymbolMNPR
Company NameMonopar Therapeutics
Listing DateDec 19, 2019
Issue Price8.00
Founded2014
CEODr. Chandler D. Robinson, M.D.
MarketNASDAQ
Employees10
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1000 Skokie Boulevard,Suite 350
CityWilmette
ProvinceIllinois
CountryUnited States of America
Zip Code60091
Phone1-847-388-0349
Websitehttp://www.monopartx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Chandler D. Robinson, M.D.
  • Chief Executive Officer and Director
  • 1.60M
  • Kim R. Tsuchimoto
  • Director, Chief Financial Officer, Principal Accounting Officer, Secretary and Treasurer
  • 695.13K
  • Andrew J. Cittadine
  • Chief Operating Officer
  • 752.33K
  • Dr. Patrice P. Rioux,M.D.,PhD
  • Acting Chief Medical Officer
  • --
  • Dr. Christopher M. Starr,PhD
  • Executive Chairman of the Board
  • 262.57K
  • Raymond William Anderson
  • Independent Director
  • 135.07K
  • Michael J. Brown, M. Sc.
  • Independent Director
  • 124.57K
  • Arthur J. Klausner
  • Independent Director
  • 127.07K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg